This Nobel Laureate Has A $1 Billion Plan To Make Gene Editing Mainstream. Plus: Pivot Your Career When The Stakes Are High


SOURCE: FORBES.COM
FEB 20, 2026

ByMaggie McGrath,

Forbes Staff

andForbesWomen Team,

Forbes Staff.

Follow Authors

Feb 20, 2026

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the newsletter list!

Alpine Skiing - Milano Cortina 2026 Winter Olympics: Day 12

CORTINA D'AMPEZZO, ITALY - FEBRUARY 18: Gold medalist Mikaela Shiffrin of Team United States celebrates on the podium during the medal ceremony following the Women's Slalom Run on day twelve of the Milano Cortina 2026 Winter Olympics at Tofane Alpine Skiing Centre on February 18, 2026 in Cortina d'Ampezzo, Italy. (Photo by Ezra Shaw/Getty Images)... More

Getty Images

We still have the Winter Olympics on the brain here at ForbesWomen, so once again, we begin our weekly newsletter with a look at what’s happening in competition (and in post-competition press conferences) in Milano-Cortina. Here’s a rundown:

The Forbes SportsMoney team is keeping a close eye on all Olympic developments here, so bookmark that link if you haven’t been able to keep up with the competition in real time!

Cheers!

Maggie McGrath

Exclusive Forbes Profile: Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

0x0-21

CODY PICKENS FOR FORBES

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream. Core to her plan is the Innovative Genomics Institute: Doudna plans to raise $1 billion for the institute to support a budget of $100 million a year for the next 10 years to set up the next generation of scientists. With that funding, she hopes to start making personalized gene editing a more widely available treatment, to use Crispr to create therapies for common diseases like cancer and even to find applications in agriculture and the environment — all in a way that’s cost-effective. “My biggest ethical concern is actually access and inequality,” Doudna tells Forbes. “We really want to make sure that the work we’re doing ultimately benefits everybody, not just a few wealthy individuals.”

LATEST NEWS

Internet of Things (IoT)


The architecture of the smart home ecosystem

MAR 15, 2026

Internet of Things (IoT)


Best IoT Courses and Certifications for 2026

MAR 15, 2026

WHAT'S TRENDING

Speech Recognition


Leading edge computing companies of 2022

JUN 02, 2022

Natural Language Processing


Who Owns Perplexity AI, the AI Search Leader?

SEP 12, 2024